Universal Exercise Unit Versus Functional Electrical Stimulation On Genu Recurvatum In Diplegic Cerebral Palsy

NCT06332729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-07-15

No results posted yet for this study

Summary

Summary:

Inclusion Criteria:

* Children aged four to eight years.
* Grade of spasticity ranging from 1 to 1+ on the Modified Ashworth scale.
* Classified as Level I or II on the Gross Motor Functional Classification System (GMFCS).
* Ability to follow verbal commands and instructions.

Exclusion Criteria:

* Previous neurological or orthopedic surgery in the lower extremities.
* Botox injection in the lower extremities within the past six months.
* Fixed deformity in the joints of the lower limb.
* Genu recarvatum secondary to surgery.
* Severe hearing and visual defects.

Materials for Subject Selection and Evaluation:

* Modified Ashworth Scale for muscle tone assessment.
* Gross Motor Functional Classification System (GMFCS) for functional activity classification.
* Digital goniometer for measuring the angle of knee hyperextension.
* Lafayette Manual Muscle Tester for quantifying muscle strength.

Methods:

* Assessment of muscle tone using the Modified Ashworth Scale, evaluating spasticity in calf muscles and hip/knee extensors.
* Evaluation of gross motor function using the GMFCS.
* Assessment of genu recarvatum using a digital goniometer.
* Assessment of muscle strength using the Lafayette Manual Muscle Tester, focusing on hamstrings and tibialis anterior muscles.
* Assessment of range of motion in the knee joint using Kinovea software.
* Treatment procedures involving physical therapy sessions with a combination of exercises and interventions tailored to each group (Group A and Group B).

Group A Treatment:

\- Designed physical therapy program combined with pulley therapy for muscle strengthening.

Group B Treatment:

\- Designed physical therapy program combined with functional electrical stimulation during walking on a treadmill for muscle stimulation.

The interventions in both groups aim to improve muscle strength, range of motion, and functional abilities in children with cerebral palsy.

Conditions

  • Cerebral Palsy

Interventions

DEVICE

universal exercis unit

Universal exercise unit (UEU) consists of system of pulleys, suspensions, belts for supporting and elastic cords. UEU is based on the concept of unloading the body against gravity and to perform movement of weak part of the body. Therapist's hands are free to provide adequate support as required by the patient during exercise training Universal exercise unit, therapy sessions extended are from three to four hours Children and adults have neurological conditions can used. Spider cage is made of metal could be depending on population pediatric or adults. Elastic resistance of cords used to increase strengthen of muscle

DEVICE

functional electrical stimulation

Functional electrical stimulation (FES) is defined as the electrical stimulation of muscles that have impaired motor control to produce a contraction to obtain functional useful movement

Sponsors & Collaborators

  • Mahmoud Reda Elsharkawy

    lead OTHER

Principal Investigators

  • Mahmoud R Elsharkawy, bachelor · Demonstrator of physical therapy at Alsalam university

  • Abd Elaziz Ali sherif, PHD · professor of pediatric department Faculty of physical therapy

  • Osama Abd Elfattah El-Agamy, PHD · Professor and head of department of pediatric faculty of medicine

  • Sara Y Abdel Elglil Elsebahy · Lecturer of pediatric department Faculty of physical therapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-05-15
Completion
2024-06-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06332729 on ClinicalTrials.gov